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ABSTRACT The properties of myosin modified at the SH2 group (Cys-697) were studied and compared with the previously
reported properties of myosin modified at the SH1 group (Cys-707). 4-[N-[(iodoacetoxy)ethyl]-N methylamino]-7-nitrobenz-
2-oxa-1,3-diazole (IANBD) was used for selective modification of the SH2 group on myosin. SH2-labeled heavy meromyosin
(SH2-HMM), similar to SH1-labeled HMM (SH1-HMM), did not propel actin filaments in the in vitro motility assays. SH1- and
SH2-HMM produced similar amounts of load in the mixtures with unmodified HMM; the sliding speed of actin filaments
gradually decreased with an increase in the fraction of either one of the modified HMMs in the mixture. In analogy to
SH1-labeled myosin subfragment 1 (SH1-S1), SH2-labeled S1 (SH2-S1) activated regulated actin in the in vitro motility
assays. SH2 modification inhibited Mg-ATPase of S1 and its activation by actin. The weak binding of S1 to actin was
unaffected whereas the strong binding was weakened by SH2 modification. Overall, our results demonstrate similar behavior
of SH1- and SH2-modified myosin heads in the in vitro motility assays despite some differences in their enzymatic properties.
The effects of these modifications are ascribed to the location of the SH1-SH2 helix relative to other functional centers of S1.
INTRODUCTION
The SH1 (Cys-707) and SH2 (Cys-697) groups are the two
most reactive cysteines on the myosin head (S1) and can be
selectively labeled with thiol reagents. SH1 and SH2 groups
are located on the opposite ends of a short -helix in the
catalytic domain of the myosin head and are separated from
one another by 19 Å (Rayment et al., 1993). This helix
(see Fig. 1) is believed to play a key role in the conforma-
tional changes that occur in the myosin head during the
force generation coupled to ATP hydrolysis. The first evi-
dence of the mobility of this helix came from cross-linking
experiments. It was shown that SH1 and SH2 groups can be
cross-linked by reagents with widely varying cross-linking
spans (5 Å to 12–14 Å), and even by disulfide bond forma-
tion, and that binding of nucleotides to S1 promotes such
cross-linking. This helix appeared also to be functionally
important; the ATPase activity of S1 was inactivated by its
cross-linking (Reisler et al., 1974b; Burke and Reisler,
1977; Wells et al., 1980), and nucleotides, if present, be-
came noncovalently trapped in the active site (Wells and
Yount, 1980).
Other indications of functional and structural importance
of this region came from studies on the selective modifica-
tion of the SH1 group on S1. It was shown that this modi-
fication affects strongly the Mg-ATP hydrolysis cycle of S1,
mostly by accelerating the release steps of ATP hydrolysis
products (Sleep et al., 1981; Ostap et al., 1993). The acti-
vation of Mg-ATPase activity of S1 by actin was also
altered greatly by SH1 modification. Mulhern and Eisen-
berg (1978) showed that such activation was almost abol-
ished irrespective of the type of label attached to SH1. More
recent studies showed that the motor function of myosin
heads in the in vitro motility assays was blocked by SH1
modification (Root and Reisler, 1992; Marriott and Hei-
decker, 1996; Bobkov et al., 1997). Moreover, the work of
Bobkov et al. (1997) revealed that SH1 modification en-
hanced the ability of S1 to activate regulated actin. The
conformation of S1 alone and in complexes with nucleo-
tides, as detected by differential scanning calorimetry study,
was also altered by SH1 modification (Golitsina et al.,
1996). According to these studies, the most pronounced
effect of SH1 modification was on the conformation of S1
in the complex with ADP and Vi, i.e., in the analog state
corresponding to the intermediate complex S1-ADP-Pi in
the Mg-ATP hydrolysis cycle of S1.
The data described above show that the SH1-SH2 helix is
a functionally important site on S1, but the mechanism by
which this helix is involved in the force generation cycle is
still unknown. It was suggested on the basis of three-
dimensional structures of the chicken skeletal S1 (Rayment
et al., 1993) and truncated Dictyostelium S1 (Fisher et al.,
1995) that during the power stroke the light-chain-binding
domain (LCBD) swings relative to the catalytic domain of
S1, acting like a lever arm. Experiments with S1 constructs
containing shortened or elongated LCBDs (Uyeda et al.,
1996) and EM reconstruction of actin filaments decorated
by S1 (Whittaker et al., 1995) led to the conclusion that the
pivot point of this swinging motion is in the vicinity of the
SH1-SH2 helix. If we assume that conformational changes
in the SH1-SH2 helix are involved in lever arm movement,
then the cross-linking of SH1 and SH2 groups or modifica-
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tion of SH1 can disrupt the mechanical function of S1 by
altering the flexibility of this helix or its coupling to the
lever arm.
Although the effects of SH1 modification on S1 proper-
ties were studied extensively, little is known about the
effects of SH2 modification on S1. Such information is
important, as a comparison of the effects of SH1 and SH2
modifications on the structure and function of S1 could
provide new insights into the role of the SH1-SH2 helix in
the generation of force. In this study, we examined the
effects of SH2 modification on the motor, regulatory, and
catalytic properties of S1 and compared them with the
effects of SH1 modification on S1.
MATERIALS AND METHODS
Reagents
(N-1[1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl]iodacetamide (IASL) was
from Aldrich (Milwaukee, WI). N-((2-(iodoacetoxy)ethyl)-N-methyl-
amino)-7-nitrobenz-2-oxa-1,3-diazole (IANBD) was from Molecular
Probes (Eugene, OR).
Proteins
Myosin and actin from back and leg muscles of rabbits were prepared
according to Godfrey and Harrington (1970) and Spudich and Watt (1971),
respectively. S1 from rabbit myosin was prepared by digestion of myosin
filaments with -chymotrypsin (Weeds and Pope, 1977). Heavy meromy-
osin was prepared according to Margossian and Lowey (1982). The con-
centrations of S1, HMM, and actin were determined spectrophotometri-
cally by using the extinction coefficients of E280
1%  7.5 cm1, E280
1%  6.0
cm1, and E290
1%  11.5 cm1, respectively. The concentrations of SH1-
modified and SH2-modified S1 and HMM were determined by using the
Bradford protein assay (Bradford, 1976).
SH1 and SH2 modifications of S1 and HMM
SH1 modification was carried out according to Reisler (1982) in solutions
containing between 10 and 20 M S1 or HMM and a 20X molar excess of
IASL. The reactions were carried out in 30 mM KCl and 20 mM Tris/HCl
at pH 7.5, at 0°C, over 1 hour. SH2 modification was performed as
described by Ajtai and Burghardt (1989) with some modifications (Root
and Reisler, 1992) in solutions containing 10 M S1 or 5 M HMM, 30
M F-actin, 4.0 mM Mg-ADP, 20 M IANBD, 30 mM KCl, and 20 mM
Tris/HCl (pH 8.0), at 0°C overnight. The SH2-modified S1 and HMMwere
separated from F-actin by ultracentrifugation in the presence of 3.0 mM
Mg-ATP and 150 mM KCl. The extent of SH1 and SH2 modifications was
determined by measuring the K-EDTA and Ca2-ATPase activities of S1
and HMM (Reisler, 1982; Ajtai and Burghardt, 1989). Typically, a 90–
98% modified S1 and HMM were used in our experiments unless stated
otherwise. More extensive labeling of myosin heads was avoided, because
it required higher reagent concentrations and longer modification times,
which could increase the probability of nonspecific modifications.
ATPase activities
The ATPase activities of S1 and HMM were measured at 37°C (Ca2- and
K-EDTA-ATPase) and 20°C (Mg2-ATPase), under steady-state condi-
tions, using the Malachite Green phosphate determination assay (Kodama
et al., 1986). The Ca2-ATPase and K-EDTA-ATPase assay solutions
contained 30 mM Tris/HCl (pH 7.5), 0.5 M KCl, and either 5.0 mM CaCl2
or 5.0 mM EDTA. Mg2-ATPase measurements were done in solutions
containing 10 mM PIPES (pH 7.0), 10 mM KCl, 3.0 mM MgCl2, and 3.0
mM ATP in the presence and absence of F-actin (between 3 and 60 M).
In vitro motility assays
In vitro motility assays were performed at 25°C as described elsewhere
(Bobkov et al., 1997). In the assays with unregulated actin, modified HMM
or mixtures of modified HMM and unmodified HMM were used with a
total HMM concentration set at 0.3 mg/ml. Movement of filaments was
initiated with solutions containing 0.4% methyl cellulose, 25 mM MOPS
(pH 7.4), 25 mM KCl, 2.0 mM MgCl2, 1.0 mM EGTA, 10 mM dithio-
threitol, 1.0 mM ATP, and an oxygen-scavenging system. In the analysis of
actin filament motility, filaments were considered to move uniformly using
criteria described previously (Homsher et al., 1996).
Motility data obtained on mixtures of unmodified HMM and either
IASL-HMM or IANBD-HMM were fitted using Eq. 1 (Cuda et al., 1997)
V grgsh1   1	1/2/
21 gs
2 gr
2	1/2,
(1)
where V is the sliding speed of actin filaments, gr and gs are the detachment
rate constants of fast and slow cycling myosin, respectively,  is the
fraction of slow cycling myosin,  is the ratio of elastic force constant of
the slow myosin to that of the fast myosin, and h is the displacement of the
myosin head during a single power stroke. h and  were allowed to float
freely in the fitting of data to Eq. 1. Fast and slow cycling myosins were
equated with unmodified and modified HMM, respectively.
The assays with regulated actin were performed using unmodified
HMM (0.3 mg/ml). Reconstitution of regulated thin filaments was carried
out by incubating overnight on ice a mixture of 2.0 M rhodamine-
phalloidin-labeled F-actin with 0.5 M bovine cardiac or skeletal tropo-
myosin and 0.5 M bovine cardiac troponin in a buffer containing 4.0 mM
imidazole/HCl at pH 7.1, 2.0 mM MgCl2, and 1.0 mM dithiothreitol.
Tropomyosin and troponin were a generous gift from Dr. Larry S. Tobac-
man. The 1.0 M SH2-modified S1 or unmodified S1 was added to this
solution in the motility activation experiments. Movement of filaments was
initiated with solutions containing the same components as in the assays
with unregulated actin except for the addition of 0.1 M tropomyosin and
0.1 M troponin and calcium to pCa 5, 7, and 8 levels. Tropomyosin and
troponin were included in the assay solution to stabilize the regulated actin
at the low protein concentration used in these experiments (Homsher et al.,
1996).
Unmodified HMM and modified S1 and HMM were pre-spun before
motility experiments with actin and ATP to remove damaged heads as
FIGURE 1 Representation of the SH1-SH2 helix based on the crystal
structure of myosin subfragment 1 (Rayment et al., 1993). SH1 (Cys-707)
and SH2 (Cys-697) groups are shown in a space-filled mode. The arrows
mark positions of two conserved glycines, 699 (upper) and 710 (lower).
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described before (Homsher et al., 1996). However, it should be noted that
this procedure had no effect on the activation of regulated actin by
modified S1 in the motility assays. Similar activation was observed with
pre-spun and unspun modified S1.
F-actin binding
The binding of S1 and SH2-modified S1 to F-actin was measured using
co-sedimentation assays (Miller and Reisler, 1995). The assay solutions
contained S1, between 5.0 and 30 M, 4.0 M phalloidin-stabilized
F-actin, 3 mM MgCl2, 10 mM KCl, 10 mM PIPES (pH 7.0), and, in the
case of weak binding, 3 mM ATP. The samples were centrifuged at room
temperature in a Beckman airfuge at 140,000 g for 10 min. Resuspended
pellets and supernatants were examined on SDS-PAGE (Laemmli, 1970).
The intensities of actin and S1 Commassie-Blue-stained bands were quan-
tified by using a Biomed Instruments softlaser densitometer (Fullerton,
CA). The values for the equilibrium dissociation constant (Kd) of S1 from
actin were obtained by fitting the data to Eq. 2:
S/A A S Kd 
A S Kd2 4AS1/2	/2A,
(2)
where S/A is the molar ratio of bound S1 to actin and A and S are the actin
and S1 concentrations, respectively.
RESULTS
In vitro motility of actin filaments over the
mixtures of unmodified and modified HMM
It was shown before that SH1 and SH2 modifications dis-
rupted the ability of myosin to propel actin filaments in the
in vitro motility assays (Root and Reisler, 1992; Marriott
and Heidecker, 1996; Bobkov et al., 1997). To shed more
light on the behavior of SH1- and SH2-modified myosin in
the in vitro motility assays, we employed an approach used
before by Cuda and colleagues (1997). Specifically, we
measured the motility of unregulated actin filaments driven
by mixtures of unmodified HMM and either SH1- or SH2-
modified HMM. The results of such measurements are
presented in Fig. 2. IASL-HMM (SH1-modified) and
IANBD-HMM (SH2-modified) showed similar behavior in
mixtures with unmodified HMM; the speed of actin fila-
ments decreased in the same manner upon increase in the
fraction of modified HMM. The speed of actin filaments
approached zero in mixtures of 10% unmodified HMM and
90% of either IASL-HMM or IANBD-HMM.
Similar experiments were performed before on mixtures
of fast-cycling myosin and either slow-cycling or noncyc-
ling myosins (Cuda et al., 1997). The slow-cycling and
noncycling myosins inhibited motility of the fast-cycling
myosin exerting a load on actin filaments. The slow-cycling
myosins loaded actin in the strongly bound state, and the
plots of the dependence of sliding speed of actin on the
fraction of the fast-cycling myosin had concave shapes for
these myosins. The noncycling myosins loaded actin in the
weakly bound state, and the plots of the dependence of
sliding speed of actin on the fraction of the fast-cycling
myosin had convex shapes for these myosins. Our motility
data for the mixtures of unmodified HMM and either IASL-
HMM or IANBD-HMM (Fig. 2) are similar to the concave
pattern shown by Cuda et al. (1997) for the mixtures of
fast-cycling myosin with slow-cycling myosins. Therefore,
we fitted our data using Eq. 1, which describes the behavior
of mixtures of fast-cycling and slow-cycling myosins. As
can be seen in Fig. 2, the calculated curve fits the experi-
mental data reasonably well except for the lower part of the
curve. There are two possible reasons for the deviation of
the data from the curve. First, speed values for the motility
of actin filaments over mixtures containing 	70% of the
modified HMM were less accurate because only a small
fraction of actin filaments moved smoothly under these
conditions. Second, the model of Cuda et al. (1997) may not
describe well the behavior of modified heads. If the devia-
tions from the calculated curve can be indeed attributed to
experimental inaccuracy, then the fit of these data to Eq. 1
provides an estimate of the drag-stroke detachment rates for
the modified HMMs (Cuda et al., 1997). The calculated
ratios of the detachment rate of unmodified HMM to that of
modified HMM (gr/gs  23) were similar for IASL-HMM
and IANBD-HMM. This suggests that the load exerted by
the modified HMMs in the motility assays may be due to the
much slower detachment rate of the modified HMMs than
that of unmodified HMM.
In vitro motility with regulated actin and
SH2-modified S1
We have shown before (Bobkov et al., 1997) that SH1-
modified myosin heads can activate regulated actin. Here,
we tested the effect of SH2 modification on activation
properties of S1 in the in vitro motility assays. As before
(Bobkov et al., 1997), to eliminate load due to the modified
heads, IANBD-S1 was added to actin in solution instead of
FIGURE 2 Relative sliding speeds of actin filaments driven by the
mixtures of unmodified HMM and either SH1-modified HMM () or
SH2-modified HMM (F). Speeds are shown relative to the speed of
unmodified HMM. The bars indicate standard deviations. Fitting the data
to Eq. 1 (only the fit for SH1-modified HMM is shown) yielded similar
values for the ratios of detachment rate of unmodified HMM to that of
modified HMM for IASL-HMM and IANBD-HMM (gr/gs  23).
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being adsorbed to the coverslips. The results of such exper-
iments are shown in Fig. 3. Open bars represent the move-
ment of regulated actin (i.e., actin complexed with troponin
and tropomyosin) propelled by unmodified HMM. This
system was fully regulated by [Ca]; the speed and the
fraction of filaments that moved declined with the decrease
in [Ca] and reached zero at pCa 8. Addition of IANBD-S1
increased the sliding speed and the fraction of actin fila-
ments that moved (Fig. 3, black bars). The activation effect
was larger at pCa 7 and 8, when actin filaments were
switched off, either partially or completely. Importantly,
when the same amount of unmodified S1 was added to the
assay solution instead of IANBD-S1, it had no effect on the
motility (Fig. 3, gray bars). The activation effect of SH1-
modified S1, which we observed before (Bobkov et al.,
1997), was similar to the effect of SH2-modified S1 de-
scribed here. The likely mechanism of this activation is that
the binding of the modified S1s (but not that of unmodified
S1 at the same concentration) switches on regulated actin.
This increases the interaction of unmodified HMM heads
with actin resulting in the increase in the fraction of fila-
ments moving and in their sliding speeds.
Thus, it appears that both SH1 and SH2 modifications
enhance the activation properties of S1 in a similar manner.
ATPase activities
It is known that, although both SH1 and SH2 modifications
inhibit the EDTA-ATPase of myosin equally well, the ef-
fects of these modifications on Ca-ATPase activities are
different. Ca-ATPase of S1 is activated strongly by SH1
modification and is left unchanged by SH2 modification
(Reisler et al., 1974a; Reisler, 1982). The effect of SH2
modification on basal Mg-ATPase activity of S1 has not
been examined yet. It was shown that SH2 modification
inhibits actin-activated ATPase of myosin (Root and Re-
isler, 1992), but the Vmax and Km values for SH2-modified
S1 have not been reported so far. Table 1 presents a com-
parison of the effects of SH1 and SH2 modifications on the
Mg-ATPase of S1 and its activation by actin. The first
striking observation is that SH1 and SH2 modifications
have opposite effects on the basal Mg-ATPase of S1. SH1
modification activates Mg-ATPase 7-fold whereas SH2
modification inhibits it 4-fold. The phosphate release step
is a rate-limiting step in the Mg-ATPase cycle of S1, and the
activation of Mg-ATPase of S1 by SH1 modification is
mostly due to the acceleration of this step (Sleep et al.,
1981). It is likely that the inhibition of basal Mg-ATPase of
S1 by SH2 modification is mostly due to inhibition of the
phosphate release step. Both SH1 and SH2 modifications
decreased the Vmax value for the S1 actin-activated ATPase.
Interestingly, IASL-S1 lost almost completely actin activa-
tion (2-fold) whereas IANBD-S1 retained a notable level
of such activation (20-fold) compared with unmodified S1
(150-fold). Both modifications decreased the Km value for
S1 actin-activated ATPase; SH1 to a greater extent than the
SH2 modification. However, the so-called enzymatic effi-
ciency (Vmax/Km) was closer to that of the native protein for
IASL-S1 than for IANBD-S1.
Actin binding
The load on unregulated actin filaments and the activation
of the regulated actin produced by SH1- and SH2-modified
heads in the in vitro motility assays imply that the acto-
myosin interactions are altered in some way by both mod-
ifications. We showed before that SH1 modification had no
effect on the strong binding and slightly reduced the weak
binding of S1 to actin (Bobkov et al., 1997). Here, we
measured the strong and weak binding of SH2-modified S1
to actin (Table 2). IANBD-S1, similar to IASL-S1, had only
a slightly reduced weak binding to actin. On the other hand,
SH2 modification decreased by15-fold the strong binding
of S1 to actin, whereas SH1 modification had no effect on
such a binding.
DISCUSSION
Atomic resolution structures of chicken skeletal S1 and of
Dictyostelium myosin S1 (S1dC) complexes with nucleo-
tides, and nucleotide and phosphate analogs (Fisher et al.,
1995; Rayment et al., 1993) confirmed the indications of
FIGURE 3 Sliding speeds (A) and the fraction of actin filaments (B) that
moved uniformly in the in vitro motility assays with regulated actin. Open
bars, actin filaments driven by unmodified HMM; gray bars, same as for
the open bars except for the presence of 1.0 M unmodified S1 in the assay
solution; black bars, same as for the open bars except for the presence of
1.0 M IANBD-S1 in the assay solution. Standard deviations are shown
for all speed measurements.
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many solution studies on the key role of the SH1-SH2 helix
in myosin function. In particular, the transition between the
Mg-ADPBeFx and Mg-ADPVi structures of S1dC, which
is believed to model the transition between the Mg-ATP and
Mg-ADPPi complexes of S1, involved changes in the
switch II loop, the lower 50K region, and in the orientation
of the SH2 group and, consequently, the pivoting of the
SH1-SH2 helix (Fisher et al., 1995; Smith and Rayment,
1996). The location of the SH2 in the atomic structure of S1
and the above observed changes in SH2 environment in the
Mg-ADPBeFx and Mg-ADPVi complexes of S1dC suggest
its involvement in signal transduction on S1 from the ATP
and actin sites to the mechanically important lever-arm
region, i.e., the light-chain-binding domain.
Despite these obvious reasons for the interest in SH2, and
in contrast to the many studies on SH1 modifications of S1,
few results are available on SH2-altered myosin. Previous
fluorescent (Hiratsuka, 1992; Phan et al., 1996) and cross-
linking experiments (Rajasekharan et al., 1989) showed
nucleotide-specific changes around SH2. Substitutions of
SH2 (cysteine 678 on Dictyostelium myosin) for serine,
alanine, threonine, and most of all, for glycine inhibited the
sliding of actin filaments over such mutant myosin (Suzuki
et al., 1997). Although these and other results are important,
they do not provide a direct comparison of the SH2 and SH1
regions and the consequences of their manipulation for
myosin functions.
The results of this study reveal some catalytic differences
between SH1- and SH2-labeled S1s. These include opposite
effects of such modifications on the basal Mg-ATPase (V0)
of S1 (activation and inhibition of the ATPase for SH1- and
SH2-labeled S1, respectively) and, related to that, signifi-
cant differences in the activation of S1 ATPase by actin
(Vmax/V0). Moreover, the strong binding of S1 to actin
appears to be unchanged for IASL-S1 although it is de-
creased almost 20-fold for IANBD-S1. On the other hand,
both SH1 and SH2 modifications have no effect on the weak
binding of S1 to actin, and both inhibit greatly the Vmax of
acto-S1 ATPase.
The above differences in the properties of SH1- and
SH2-labeled S1, although not predictable, can be easily
rationalized by assuming that the SH1-SH2 helix does not
necessarily change as a single cooperative unit. In such a
scenario, probes attached to SH2 and SH1 may have differ-
ent effects on the local structure, flexibility, and mobility of
the SH2 site and, consequently, via the switch II loop, on the
catalytic events on S1. This idea is supported by recent
mutational studies of Kinose et al. (1996) and Patterson et
al. (1997) in which substitutions of Gly-680 (i.e., Gly-699 in
skeletal myosin, next to SH2) and Gly-691 (i.e., Gly-710 in
skeletal myosin, close to SH1) had similar, (i.e., opposing)
effects on the basal Mg-ATPase of myosin to those shown
for IASL-S1 and IANBD-S1 in this work.
Strikingly and importantly, the mechanical consequences
of SH1 and SH2 modifications are virtually identical. Com-
pletely modified proteins do not move actin in the in vitro
motility assays, and they introduce similar load into such
assays in mixtures of modified and unmodified HMM. Both
SH1- and SH2-modified HMMs have 23-fold slower de-
tachment rates from actin than the unmodified HMM if the
Cuda et al. (1997) model is adopted for the analysis of our
motility data. However, on their own, such slow detachment
rates do not explain the loss of myosin’s mechanical func-
tion; myosins with even slower detachment rates can move
actin filaments (Cuda et al., 1997). It is also difficult to
justify the mechanical inactivation of IANBD-HMM by
changes in actin activation of Mg-ATPase. Although such a
connection is valid for IASL-S1, with Vmax/V0  2.3, the
larger actin activation of IANBD-S1 Mg-ATPase by actin,
Vmax/V0  23, does not preclude the mechanical function
for SH2-modified myosin. In this sense, SH2 modification
achieves a greater uncoupling between the lever-arm and
catalytic domains on S1 than the SH1 labeling.
The common denominator of both SH1 and SH2 modi-
fications is most likely the change in the flexibility/mobility
TABLE 1 Actin-activated and basal Mg-ATPase activities of SH1 (IASL-S1) and SH2-modified (IANBD-S1) S1
Protein
Mg-ATPase
V0 (s
1)
Actin-activated ATPase
Activation
Vmax/V0Vmax (s
1) Km (M) Vmax/Km
S1 0.056  0.005 8.3  1.7 30.0  7.0 0.28 148
IANBD-S1 0.015  0.001 0.35  0.05 8.4  0.8 0.042 23
IASL-S1 0.40  0.04 0.93  0.02 2.0  0.2 0.47 2.3
The ATPase activities were measured at 20°C in 10 mM PIPES (pH 7.0), 10 mM KCl, 3.0 mM MgCl2, and 3.0 mM ATP. Actin-activated ATPase assays
contained also between 3.0 and 60 M F-actin. The Km and Vmax values were obtained by fitting the data to the Michaelis-Menten equation. Each value
is an average of at least three independent measurements. Data for IASL-S1 are taken from Bobkov et al. (1997).
TABLE 2 Equilibrium dissociation constants (Kd) for the
complexes of actin with SH1 (IASL-S1) and SH2-modified
(IANBD-S1) S1
Kd (M)
No nucleotides ATP
S1 0.03  0.01 33  9
IANBD-S1 0.51  0.26 42  7
IASL-S1 0.03  0.01 47  12
Dissociation constants for unmodified S1 and IANBD-S1 were determined
using co-sedimentation assays. Assay solutions contained S1, between 5.0
and 30 M, 4.0 M phalloidin-stabilized F-actin, 10 mM PIPES (pH 7.0),
10 mM KCl, and 3 mM MgCl2. The weak binding was measured in the
presence of 3.0 mM ATP. At least three separate determinations were made
for each Kd value. Data for IASL-S1 are taken from Bobkov et al. (1997).
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of the corresponding parts of the SH1-SH2 helix. How
extensive is the change may depend on the nature of the
probe that is attached at these sites. It is also not clear yet
whether these changes involve the reorientation of the SH2
or SH1, a partial immobilization of reactive SH groups, or
just the opposite, a local unfolding of the helix. Support for
flexibility-based explanations comes from two sources.
Specific nucleotide effects on SH2- and SH1-attached
probes (Hiratsuka, 1992; Phan et al., 1996) do not indicate
an unfolded environment. More importantly, the replace-
ment of Gly-699 on myosin (or its Dictyostelium counter-
part) brought the actin motion almost to a halt (Kinose et al.,
1996; Patterson et al., 1997), and that of Gly-710 also
decreased significantly the in vitro motion of actin. A tempt-
ing hypothesis is that both the mutations and SH1 and SH2
modifications alter the flexibility of the corresponding re-
gion in the SH1-SH2 helix. Accordingly, the mechanical
function of the lever arm can be disrupted by changes in the
flexibility at either the SH1 or SH2 site. The proposed
swinging of the lever arm of S1 relative to the catalytic
domain, with the pivot point located in the vicinity of the
SH1-SH2 helix (Uyeda et al., 1996; Whittaker et al., 1995;
Suzuki et al., 1997) appears to depend on the structural
integrity and flexibility at both SH1 and SH2. Clearly,
although such a speculative explanation of our results can
account for different catalytic but similar mechanical results
of SH1 and SH2 modifications, it does not clarify the
similar activation of regulated actin filaments by IASL-S1
and IAMSD-S1. The mechanistic explanation of this effect
awaits further investigation.
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